We are proud to share that Dr. Venkata Pradeep Babu Koyyala, Director of Shankara Cancer and Research Institute (SCRI), participated as a contributor at RGCON 2026, the prestigious annual international oncology conference organized by Rajiv Gandhi Cancer Institute and Research Centre (RGCIRC), New Delhi — his alma mater.
Held from 13th–15th March 2026, RGCON 2026 brought together leading national and international experts in oncology and allied specialties to deliberate on the latest advancements in multidisciplinary cancer care, precision oncology, neuro-oncology, and evidence-based treatment approaches.
Dr. Venkata actively contributed to scientific discussions and academic exchanges with eminent oncology experts from across India and abroad, reflecting SCRI’s continued commitment towards advancing knowledge-driven and patient-centric cancer care.
The conference provided valuable insights into:
• Advances in precision oncology and personalized treatment strategies
• Emerging developments in neuro-oncology and brain tumor management
• Integration of technology and research into clinical oncology practice
• Strengthening multidisciplinary collaboration for improved patient outcomes
Participation in such globally relevant scientific forums enables the translation of evolving oncology advancements into meaningful clinical impact for patients, particularly in Northeast India.
SCRI remains committed to continuous learning, collaboration, and the delivery of accessible, evidence-based, and compassionate cancer care.
#RGCON2026 #SCRI #Oncology #CancerCare #MedicalOncology #EvidenceBasedMedicine #HealthcareIndia #CancerResearch #PatientFirst
